Authors:
Sidwell, RW
Smee, DF
Bailey, KW
Burger, RA
Citation: Rw. Sidwell et al., Primary immune system effects of the orally administered cyclopentane neuraminidase inhibitor RWJ-270201 in influenza virus-infected mice, INT IMMUNO, 1(6), 2001, pp. 1211-1218
Authors:
Smee, DF
Sidwell, RW
Morrison, AC
Bailey, KW
Baum, EZ
Ly, L
Wagaman, PC
Citation: Df. Smee et al., Characterization of an influenza A (H3N2) virus resistant to the cyclopentane neuraminidase inhibitor RWJ-270201, ANTIVIR RES, 52(3), 2001, pp. 251-259
Citation: Df. Smee et al., Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice, ANTIVIR RES, 52(1), 2001, pp. 55-62
Citation: Rw. Sidwell et al., Influence of virus strain, challenge dose, and time of therapy initiation on the in vivo influenza inhibitory effects of RWJ-270201, ANTIVIR RES, 51(3), 2001, pp. 179-187
Citation: Df. Smee et al., Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities, ANTIM AG CH, 45(3), 2001, pp. 743-748
Citation: Rw. Sidwell et al., In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RWJ-270201, ANTIM AG CH, 45(3), 2001, pp. 749-757
Citation: Df. Smee et al., Treatment of cowpox virus respiratory infections in mice with ribavirin asa single agent or followed sequentially by cidofovir, ANTIVIR CHE, 11(4), 2000, pp. 303-309